These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11233909)

  • 41. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
    Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
    Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of allograft tolerance with neonatal skin.
    Jamshidi F; De Fazio SR; Markees TG; Gozzo JJ
    Transplantation; 1991 May; 51(5):1048-52. PubMed ID: 2031261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of natural killer cells in the rejection of hamster skin xenografts.
    Gourlay WA; Chambers WH; Monaco AP; Maki T
    Transplantation; 1998 Mar; 65(5):727-34. PubMed ID: 9521210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infectious tolerance develops after intrathymic alloantigen-induced acceptance of rat heart allografts can be adoptively transferred.
    Takayashiki T; Asakura H; Ku G; Kataoka M; Flye MW
    Surgery; 2005 Aug; 138(2):254-60. PubMed ID: 16153434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunologic mechanism following liver transplantation. An experimental study in the rat].
    Lie TS; Galkowska H; Jaeger K; Niehaus KJ
    Langenbecks Arch Chir; 1983; 360(1):17-27. PubMed ID: 6348454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
    Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
    Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunological tolerance induced by liver grafting in the rat: splenic macrophages and T cells mediate distinct phases of immunosuppressive activity.
    Yoshimura S; Gotoh S; Kamada N
    Clin Exp Immunol; 1991 Jul; 85(1):121-7. PubMed ID: 1829989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Correlation of transplantation tolerance and chimerism induced by allogeneic parabiosis in adult rats].
    Shi Q; Xie S; Yu L
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):602-5. PubMed ID: 11798826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of donor-specific tolerance to rat cardiac and small bowel allografts by intrathymic inoculation of donor T-cells.
    Chowdhury NC; Fawwaz RA; Oluwole SF
    J Surg Res; 1993 Apr; 54(4):368-74. PubMed ID: 8331931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice.
    Onzuka T; Tomita Y; Okano S; Shimizu I; Yamada H; Yoshikai Y; Tominaga R
    Scand J Immunol; 2010 Aug; 72(2):106-17. PubMed ID: 20618769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
    Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
    Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues.
    Bishop GA; Sun J; DeCruz DJ; Rokahr KL; Sedgwick JD; Sheil AG; Gallagher ND; McCaughan GW
    J Immunol; 1996 Jun; 156(12):4925-31. PubMed ID: 8648143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory cells develop after the spontaneous acceptance of rat liver allografts.
    Asakura H; Ku G; Kataoka M; Flye MW
    Surgery; 2004 Sep; 136(3):532-6. PubMed ID: 15349099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts.
    Cunningham EC; Tay SS; Wang C; Rtshiladze M; Wang ZZ; McGuffog C; Cubitt J; McCaughan GW; Alexander IE; Bertolino P; Sharland AF; Bowen DG; Bishop GA
    Transplantation; 2013 Jan; 95(1):70-7. PubMed ID: 23263501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.